Advancing Standards in Regenerative Medicine Act
Sponsored By: Representative Foster, Bill [D-IL-11]
Unknown
Summary
Advancing Standards in Regenerative Medicine Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Foster, Bill [D-IL-11]
IL • D
Cosponsors
Rep. Ryan, Tim [D-OH-13]
OH • D
Sponsored 6/3/2016
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov